USA flag logo/image

An Official Website of the United States Government

THE PURPOSE OF THIS GRANT IS TO SELECT APPROVABLE DRUGS FOR THE TREATMENT OF…

Award Information

Agency:
Department of Health and Human Services 		Branch:
N/A 		Award ID:
470 		Program Year/Program:
1983 / SBIR
Agency Tracking Number:
470 		Solicitation Year:
N/A 		Solicitation Topic Code:
N/A 		Solicitation Number:
N/A
Small Business Information
Atmospheric Health Sciences
152 Parsonage Hill Road P.o. Box 307 Short Hills, NJ 07078
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1983
Title: THE PURPOSE OF THIS GRANT IS TO SELECT APPROVABLE DRUGS FOR THE TREATMENT OF FOUR ORPHAN DISEASES: SICKLE CELL DISEASE,THALASSEMIA, HEMOCHROMATOSIS, AND ERYTHROPOIETIC PORPHYRIAS.
Agency: HHS
Contract: N/A
Award Amount: $56,000.00
 

Abstract:

THE PURPOSE OF THIS GRANT IS TO SELECT APPROVABLE DRUGS FOR THE TREATMENT OF FOUR ORPHAN DISEASES: SICKLE CELL DISEASE,THALASSEMIA, HEMOCHROMATOSIS, AND ERYTHROPOIETIC PORPHYRIAS.FROM THE AVAILABLE WORLD MEDICAL LITERATURE ON THE FOUR DISEASES, DRUGS THAT ARE CLAIMED TO BE EFFECTIVE WILL BE EVALUATED AND CATEGORIZED AS TO THE EXTENT OF CLINICAL TESTING AND ANIMAL EXPERIMENTATION. THE THERAPEUTIC REVIEWS WILL BE EXAMINED BY A GROUP OF CONSULTANTS WHO WILL IN TURN SELECT APPROVABLE DRUGS FOR SUBMISSION TO THE ORPHAN PRODUCTS BOARD. PROMISING DRUGS THAT NEED ADDITIONALBUT MINIMAL RESEARCH WILL BE SELECTED FOR PHASE II STUDIES ON ANIMALS AND PATIENTS. IT IS EXPECTED THAT THIS PROJECT WILL HASTEN THE SELECTION PROCESS AND COMMERCIAL INTRODUCTION OF DRUGS FOR ORPHAN DISEASES IN GENERAL, PARTICULARLY OF HEREDITARY ERYTHROCYTIC DISEASES.

Principal Investigator:

Domingo m. aviado
PRINCIPAL INVESTIGATOR
2013793141

Business Contact:

Small Business Information at Submission:

Atmospheric Health Sciences
152 Parsonage Hill Road P.o. Box 307 Short Hills, NJ 07078

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No